Skip to main content

Zemocimig

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number2955620-21-8
Known Aliases (3)
Common Name
Immunoglobulin G4 [180-lysine,201-glutamine,230-proline,298-tyrosine,358-lysine,411-lysine,430-leucine,436-alanine,440-arginine,442-glutamic acid,447-proline,de-448-glycine,de-449-lysine], bispecific, anti-(human/Macaca fascicularis blood-coagulation factor IXa) (human-Rattus norvegicus monoclonal AAE0252 γ4-chain), disulfide with human monoclonal AAE0252 κ-chain, (228→225′),(231→228′)-bis(disulfide) with immunoglobulin G4 [149-glutamic acid,177-glutamic acid,198-glutamine,227-proline,295-tyrosine,408-lysine,427-leucine,433-alanine,437-arginine,438-glutamic acid,439-glutamic acid,444-proline,de-445-glycine,de-446-lysine] anti-(human blood-coagulation factor X) (human-Mus musculus monoclonal AAE0252 γ4-chain) disulfide with human monoclonal AAE0252 λ-chain immunoglobulin (H-gamma4_L-kappa)_( H-gamma4_L-lambda2), anti-[Homo sapiens F9a (coagulation factor F9, coagulation factor IX, hemophilia B) activated ] and anti-[Homo sapiens F10 (coagulation factor 10, coagulation factor X)], humanized and Homo sapiens monoclonal antibody, bispecific, bivalent zemocimig [INN]
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) SZN3M97G43 Zemocimig CAS: 2955620-21-8
INN: 13346
FDA UNII: SZN3M97G43
Record Info
ID4cJoPpEm2sYPRYg49W6ttj
CreatedApril 10, 2026, 9:39 p.m.
ModifiedApril 10, 2026, 11:04 p.m.
Data SourceFDA Substance Registry (openFDA)